{"id":5312,"date":"2008-12-27T08:44:55","date_gmt":"2008-12-27T07:44:55","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=5312"},"modified":"2008-12-27T08:44:55","modified_gmt":"2008-12-27T07:44:55","slug":"48th-annual-international-conference-on-antimicrobial-agents-and-chemotherapy-icaac","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/5312","title":{"rendered":"48th Annual International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 25-28 October 2008, Washington DC"},"content":{"rendered":"<h2>48th ICAAC and IDSA joint meeting<\/h2>\n<p> <a href=\"https:\/\/i-base.info\/htb\/keyword\/icaac-48th-2008\">Reports from the conference<\/a><\/p>\n<p>We were not able to attend the 48th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC) this year, which has gradually reduced its focus on HIV, although this year the meeting was combined annual IDSA meeting.<\/p>\n<p>Unfortunately, ICAAC continues to make few presentations available online, and only limited access to abstracts (which usually are removed within a month or so of the meeting finishing.<\/p>\n<p>Nevertheless, some of the interesting studies reported below include: <\/p>\n<ul>\n<li><a title=\"Permanent link to Antiretroviral Pregnancy Registry finds no increase in congenital anomalies with exposure to tenofovir\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/342\">Antiretroviral Pregnancy Registry finds no increase in congenital anomalies with exposure to tenofovir<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to No association between maternal antiretrovirals in pregnancy and congenital anomalies\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/340\">No association between maternal antiretrovirals in pregnancy and congenital anomalies<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Pharmacokinetics of saquinavir\/ritonavir in pregnancy\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/338\">Pharmacokinetics of saquinavir\/ritonavir in pregnancy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Course of labour in pregnant HIV-positive women with no contraindication for vaginal delivery\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/336\">Course of labour in pregnant HIV-positive women with no contraindication for vaginal delivery<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Four weeks of antiretroviral prophylaxis is sufficient for HIV-exposed infants\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/334\">Four weeks of antiretroviral prophylaxis is sufficient for HIV-exposed infants<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to HAART suppresses genital tract HIV shedding in HIV\/HSV co-infected women\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/332\">HAART suppresses genital tract HIV shedding in HIV\/HSV co-infected women<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Efavirenz significantly reduces levels of some oral contraceptives\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/330\">Efavirenz significantly reduces levels of some oral contraceptives<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Lack of efficacy of isoniazid (INH) prophylaxis and PK evaluation in South African infants\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/326\">Lack of efficacy of isoniazid (INH) prophylaxis and PK evaluation in South African infants<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to 48-week data for darunavir\/ritonavir (DRV\/r) in treatment-experienced children and adolescents\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/324\">48-week data for darunavir\/ritonavir (DRV\/r) in treatment-experienced children and adolescents<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Greater lipodystrophy risk in older US children with low viral load\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/322\">Greater lipodystrophy risk in older US children with low viral load<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Studies of pipeline drugs: RDEA806, PRO140, bevirimat, elvucitabine\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/317\">Studies of pipeline drugs: RDEA806, PRO140, bevirimat, elvucitabine<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Maraviroc trial results reanalysed using more sensitive CCR5 tropism test\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/315\">Maraviroc trial results reanalysed using more sensitive CCR5 tropism test<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Other antiretroviral studies at ICAAC\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/310\">Other antiretroviral studies at ICAAC<\/a>:\u00a0Early HAART may improve survival;\u00a0Raltegravir in treatment-naive patients;\u00a0Darunavir is comparable to lopinavir in treatment-naive patients;\u00a0Atazanavir is comparable to lopinavir in treatment-naive patients.<\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to High rate of rash in HIV-negative volunteers combining raltegravir and darunavir\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/308\">High rate of rash in HIV-negative volunteers combining raltegravir and darunavir<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Bone loss in SMART study\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/305\">Bone loss in SMART study<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Parathyroid hormone and vitamin D levels in patients using tenofovir\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/303\">Parathyroid hormone and vitamin D levels in patients using tenofovir<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Haemoglobin A1c (HbA1c) may underestimate glycaemia in patients with diabetes on HIV therapy\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/299\">Haemoglobin A1c (HbA1c) may underestimate glycaemia in patients with diabetes on HIV therapy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Statin use in HIV-positive  patients\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/297\">Statin use in HIV-positive patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to HIV reinfection reported in 10% of couples in Zambian study\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/292\">HIV reinfection reported in 10% of couples in Zambian study<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Drug interaction studies with approved drugs\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/289\">Drug interaction studies with approved drugs<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Non alcoholic fatty liver disease (NAFLD) is common among HIV-positive patients\" rel=\"bookmark\" href=\"https:\/\/i-base.info\/htb\/295\">Non alcoholic fatty liver disease (NAFLD) is common among HIV-positive patients<\/a><\/li>\n<\/ul>\n<p> Unless stated otherwise, all references are to the Programme and Abstract of the 48th Annual ICAAC. Abstracts only remain online (follow the link to the Programme Planner) for a short period after the conference ends.<\/p>\n<p><a href=\"http:\/\/www.icaacidsa2008.org\"><span>http:\/\/www.icaacidsa2008.org<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>48th ICAAC and IDSA joint meeting Reports from the conference We were not able to attend the 48th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC) this year, which has gradually reduced its focus on HIV, although this year the &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,102],"class_list":["post-5312","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-icaac-48th-2008"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/5312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=5312"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/5312\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=5312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=5312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=5312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}